CTX And P1NP Are The Bone Health Markers That Actually Show What's Happening Right Now
OsteoIQ®, a bone health intelligence company, today announced the broad availability of its at-home Bone Turnover Marker Bundle, which measures both CTX and P1NP, the two markers most widely recognized in osteoporosis care for tracking bone remodeling as it occurs. The test is available worldwide, starts at $269, and requires no clinical referral.
The Problem With Waiting for a Scan A DXA scan is a record of what already happened. It captures accumulated bone loss at a single point in time. By the time the image shows a meaningful change, the biological process driving that change has typically been active for an extended period. That's not a flaw in the technology. It's simply what the technology measures.
CTX and P1NP operate differently. CTX reflects current bone breakdown activity. P1NP reflects current bone formation. Together, they reveal what the body is doing with bone right now, not months after the fact. That's the fundamental difference between a lagging indicator and a leading one.
Consider someone who has overhauled their nutrition, started a resistance training program, and added targeted supplementation. Without objective data, there's no real way to know whether any of that is registering biologically until a future scan reflects the cumulative outcome. With CTX and P1NP results in hand, the biological signal is available far sooner. That's the gap OsteoIQ® is designed to close.
How the Testing Model Works Because bone health is a process and not a single event, OsteoIQ®'s Bone Turnover Marker Bundle is built for repeat testing. Individuals can test every 3, 6, or 12 months depending on their goals and circumstances. A single test tells you where things stand today. A series of tests tells you which direction things are moving and whether the actions you're taking are actually producing a response in the bone.
Every bundle purchase includes access to the OsteoIQ® Bone Health Intelligence app, which translates raw lab values into personalized, actionable insights. Lab numbers without context leave most people uncertain about what the numbers mean and what to do next. The app addresses that directly.
One honest note: biomarker testing surfaces what's happening biologically at the time of the test. It doesn't replace clinical judgment, and for individuals with specific medical concerns, a healthcare provider remains part of the picture. What the data does is give both individuals and their practitioners something concrete and current to act on, rather than waiting for symptoms or a delayed scan to surface a problem that's been building for months.
Adding a Genetic Layer For those who want to understand not just what their bone biology is doing now but what it's predisposed toward, OsteoIQ® Optimal Genomics adds a personal genetic picture of bone health risk factors. Certain genetic variants influence how the body builds and maintains bone, how it responds to key nutrients, and how it regulates the factors that drive bone turnover. Unlike biomarker results, which shift over time in response to what you're doing, your genetics don't change. That's why Optimal Genomics is a one-time test starting at $379, and why the insight it generates continues to inform how ongoing biomarker results are read and acted on over time.
Neither test alone tells the whole story. Biomarker data shows the current signal. Genomic data provides the context that helps interpret it. Used together, they offer something neither provides independently.
Accessible Wherever Bone Loss Doesn't Wait Bone health risk isn't concentrated in cities with convenient access to specialists or DXA facilities. OsteoIQ®'s direct-to-consumer model removes the geographic and logistical barriers that have historically made this level of testing inaccessible for most people. Order from anywhere in the world. Test at home. Get results and personalized guidance through the Bone Health Intelligence app.
Education without measurement is a plan without feedback. The data exists to track bone health in real time. OsteoIQ® makes it accessible without a referral, a clinic visit, or a wait.
About OsteoIQ®
OsteoIQ® is a bone health intelligence company offering at-home bone turnover marker testing and genomic insights through a direct-to-consumer model available worldwide. Its Bone Turnover Marker Bundle measures CTX and P1NP and starts at $269. Its Optimal Genomics test provides a personal genetic picture of bone health risk factors and starts at $379 as a one-time test. Every test purchase includes access to the OsteoIQ® Bone Health Intelligence app, which delivers personalized, data-driven insights to support proactive bone health management. Learn more at osteoiq.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment